Case Report: The JAK-Inhibitor Ruxolitinib Use in Aicardi-Goutieres Syndrome Due to ADAR1 Mutation

• প্রধান লেখক: Marco Cattalini (লেখক), Jessica Galli (লেখক), Fiammetta Zunica (লেখক), Rosalba Monica Ferraro (লেখক), Marialuisa Carpanelli (লেখক), Simona Orcesi (লেখক), Giovanni Palumbo (লেখক), Lorenzo Pinelli (লেখক), Silvia Giliani (লেখক), Elisa Fazzi (লেখক), Raffaele Badolato (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Frontiers Media S.A., 2021-10-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Type I Interferonopathies comprise inherited inflammatory diseases associated with perturbation of the type I IFN response. Use of Janus kinase (JAK) inhibitors has been recently reported as possible tools for treating some of those rare diseases. We describe herein the clinical picture and treatmen...